Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
AI Proteins Announces the Formation of a Scientific Advisory Board Made up of Experts in Biotech and FDA Drug Approval
AI Proteins, a growing biotechnology company that utilizes computational de novo protein design to create […]
smartbax Announces Seed Financing of €1.2 Million to Develop Next-generation Antibiotics
smartbax, a biotech company developing next-generation antibiotics against multi-drug resistant bacteria, today announced the close […]
Ironwood Enters into Definitive Agreement to Acquire VectivBio, a Clinical-Stage Biotech Company Pioneering Novel Treatments for Severe Rare Gastrointestinal Diseases
Ironwood Pharmaceuticals, a GI-focused healthcare company, and VectivBio Holding AG, a clinical-stage biopharmaceutical company pioneering […]
Vicinitas Therapeutics Appoints Christian Hofmann, Ph.D., as Chief Executive Officer
Vicinitas Therapeutics, a biotechnology company advancing a proprietary targeted protein stabilization platform to develop novel […]
n-Lorem Foundation Awarded Prestigious 2023 Edison Award
n-Lorem, a nonprofit Foundation, today announced that it has been selected as a 2023 Edison […]
ImmVira Appoints Dr. Oliver Kong as Chief Medical Officer
ImmVira, a biotechnology company focused on developing and synthesizing biological vector delivery platform, has announced […]
Novo Holdings Invests in US$105 Million Series C Funding of Alentis Therapeutics
Novo Holdings A/S, a leading international life sciences investor, today announced it has participated in […]
ProJenX Announces Formation of Scientific Advisory Board for Development of ALS Treatment
ProJenX, a clinical-stage biotechnology company developing novel, brain-penetrant therapies targeting biologically-defined pathways for the treatment […]
Granular Therapeutics to Accelerate Development of Next-Generation Pipeline for Treating Mast Cell Driven Diseases
Granular Therapeutics, a private biotech company specialising in precision biologic therapies for treating mast cell […]
PharmaVentures Establishes an Office in Seoul to Enhance Access for South Korean Biotechs
PharmaVentures announces its new office in South Korea as part of its continued strategic expansion. […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more